Stay updated on Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.

Latest updates to the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.6.5 appears in the page footer, replacing the previous v3.6.4. This indicates a minor platform/template update for the study record.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision label in the footer was updated from v3.6.3 to v3.6.4, indicating a small site update.SummaryDifference0.0%

- Check26 days agoChange DetectedSteatotic Liver Disease has been added to the glossary to reflect updated terminology for liver fat-related conditions used on this study page. Fatty Liver Disease has been removed from the glossary.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page's revision label updates from v3.6.2 to v3.6.3, indicating a small platform/template update rather than changes to study information.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now displays the updated Revision: v3.6.2, replacing the prior Revision: v3.6.0.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0; metadata labels are standardized (Last Verified, Last Known Status Was) and the Intervention/Treatment heading is reformatted.SummaryDifference0.9%

Stay in the know with updates to Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.